vs
Encompass Health Corp（EHC）与罗布乐思（RBLX）财务数据对比。点击上方公司名可切换其他公司
Encompass Health Corp的季度营收约是罗布乐思的1.1倍（$1.5B vs $1.4B），Encompass Health Corp净利率更高（9.5% vs -22.3%，领先31.8%），罗布乐思同比增速更快（43.2% vs 9.9%），罗布乐思自由现金流更多（$308.6M vs $116.7M），过去两年罗布乐思的营收复合增速更高（32.9% vs 8.3%）
Encompass Health Corp前身为Amcare及HealthSouth，总部位于美国阿拉巴马州伯明翰，是美国规模最大的住院康复服务提供商，在39个州及波多黎各拥有173家住院康复医院，为中风、神经系统疾病、心肺病症、脑损伤等患者提供专业康复诊疗服务。
罗布乐思（Roblox Corporation）是总部位于美国加利福尼亚州圣马特奥的游戏企业，由大卫·巴斯祖奇与埃里克·卡塞尔于2004年共同创立。公司核心产品为同名线上游戏创作平台Roblox，于2006年正式上线，截至2024年12月底全球员工规模已超2400人。
EHC vs RBLX — 直观对比
营收规模更大
EHC
是对方的1.1倍
$1.4B
营收增速更快
RBLX
高出33.3%
9.9%
净利率更高
EHC
高出31.8%
-22.3%
自由现金流更多
RBLX
多$191.9M
$116.7M
两年增速更快
RBLX
近两年复合增速
8.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.5B | $1.4B |
| 净利润 | $146.1M | $-316.0M |
| 毛利率 | — | 77.7% |
| 营业利润率 | 16.7% | -25.3% |
| 净利率 | 9.5% | -22.3% |
| 营收同比 | 9.9% | 43.2% |
| 净利润同比 | 20.8% | -43.9% |
| 每股收益（稀释后） | $1.43 | $-0.44 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EHCRBLX
| Q4 25 | $1.5B | $1.4B | ||
| Q3 25 | $1.5B | $1.4B | ||
| Q2 25 | $1.5B | $1.1B | ||
| Q1 25 | $1.5B | $1.0B | ||
| Q4 24 | $1.4B | $988.2M | ||
| Q3 24 | $1.4B | $919.0M | ||
| Q2 24 | $1.3B | $893.5M | ||
| Q1 24 | $1.3B | $801.3M |
净利润EHCRBLX
| Q4 25 | $146.1M | $-316.0M | ||
| Q3 25 | $126.5M | $-255.6M | ||
| Q2 25 | $142.1M | $-278.4M | ||
| Q1 25 | $151.5M | $-215.1M | ||
| Q4 24 | $120.9M | $-219.6M | ||
| Q3 24 | $108.2M | $-239.3M | ||
| Q2 24 | $114.1M | $-205.9M | ||
| Q1 24 | $112.5M | $-270.6M |
毛利率EHCRBLX
| Q4 25 | — | 77.7% | ||
| Q3 25 | — | 78.2% | ||
| Q2 25 | — | 78.2% | ||
| Q1 25 | — | 78.3% | ||
| Q4 24 | — | 77.9% | ||
| Q3 24 | — | 77.7% | ||
| Q2 24 | — | 77.8% | ||
| Q1 24 | — | 77.7% |
营业利润率EHCRBLX
| Q4 25 | 16.7% | -25.3% | ||
| Q3 25 | 14.9% | -21.8% | ||
| Q2 25 | 16.2% | -29.8% | ||
| Q1 25 | 16.4% | -24.6% | ||
| Q4 24 | 14.3% | -24.7% | ||
| Q3 24 | 13.6% | -30.4% | ||
| Q2 24 | 14.3% | -26.6% | ||
| Q1 24 | 13.6% | -37.7% |
净利率EHCRBLX
| Q4 25 | 9.5% | -22.3% | ||
| Q3 25 | 8.6% | -18.8% | ||
| Q2 25 | 9.7% | -25.8% | ||
| Q1 25 | 10.4% | -20.8% | ||
| Q4 24 | 8.6% | -22.2% | ||
| Q3 24 | 8.0% | -26.0% | ||
| Q2 24 | 8.8% | -23.0% | ||
| Q1 24 | 8.5% | -33.8% |
每股收益（稀释后）EHCRBLX
| Q4 25 | $1.43 | $-0.44 | ||
| Q3 25 | $1.24 | $-0.37 | ||
| Q2 25 | $1.39 | $-0.41 | ||
| Q1 25 | $1.48 | $-0.32 | ||
| Q4 24 | $1.18 | $-0.32 | ||
| Q3 24 | $1.06 | $-0.37 | ||
| Q2 24 | $1.12 | $-0.32 | ||
| Q1 24 | $1.10 | $-0.43 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $72.2M | $3.1B |
| 总债务越低越好 | $2.4B | $1.2B |
| 股东权益账面价值 | $2.4B | $394.5M |
| 总资产 | $7.1B | $9.6B |
| 负债/权益比越低杠杆越低 | 1.00× | 2.98× |
8季度趋势，按日历期对齐
现金及短期投资EHCRBLX
| Q4 25 | $72.2M | $3.1B | ||
| Q3 25 | $48.7M | $2.9B | ||
| Q2 25 | $99.1M | $2.6B | ||
| Q1 25 | $95.8M | $2.7B | ||
| Q4 24 | $85.4M | $2.4B | ||
| Q3 24 | $147.8M | $2.3B | ||
| Q2 24 | $154.4M | $2.4B | ||
| Q1 24 | $134.4M | $2.4B |
总债务EHCRBLX
| Q4 25 | $2.4B | $1.2B | ||
| Q3 25 | $2.4B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.3B | — | ||
| Q4 24 | $2.4B | $1.2B | ||
| Q3 24 | $2.3B | — | ||
| Q2 24 | $2.7B | — | ||
| Q1 24 | $2.7B | — |
股东权益EHCRBLX
| Q4 25 | $2.4B | $394.5M | ||
| Q3 25 | $2.4B | $407.6M | ||
| Q2 25 | $2.3B | $353.2M | ||
| Q1 25 | $2.2B | $310.7M | ||
| Q4 24 | $2.1B | $221.4M | ||
| Q3 24 | $2.0B | $189.9M | ||
| Q2 24 | $1.8B | $121.5M | ||
| Q1 24 | $1.7B | $71.6M |
总资产EHCRBLX
| Q4 25 | $7.1B | $9.6B | ||
| Q3 25 | $6.9B | $8.6B | ||
| Q2 25 | $6.8B | $7.8B | ||
| Q1 25 | $6.6B | $7.5B | ||
| Q4 24 | $6.5B | $7.2B | ||
| Q3 24 | $6.5B | $6.7B | ||
| Q2 24 | $6.4B | $6.5B | ||
| Q1 24 | $6.2B | $6.3B |
负债/权益比EHCRBLX
| Q4 25 | 1.00× | 2.98× | ||
| Q3 25 | 1.01× | — | ||
| Q2 25 | 1.02× | — | ||
| Q1 25 | 1.08× | — | ||
| Q4 24 | 1.14× | 5.48× | ||
| Q3 24 | 1.20× | — | ||
| Q2 24 | 1.46× | — | ||
| Q1 24 | 1.54× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $346.0M | $607.0M |
| 自由现金流经营现金流 - 资本支出 | $116.7M | $308.6M |
| 自由现金流率自由现金流/营收 | 7.6% | 21.8% |
| 资本支出强度资本支出/营收 | 14.8% | 21.1% |
| 现金转化率经营现金流/净利润 | 2.37× | — |
| 过去12个月自由现金流最近4个季度 | $439.2M | $1.4B |
8季度趋势，按日历期对齐
经营现金流EHCRBLX
| Q4 25 | $346.0M | $607.0M | ||
| Q3 25 | $270.8M | $546.2M | ||
| Q2 25 | $270.2M | $199.3M | ||
| Q1 25 | $288.6M | $443.9M | ||
| Q4 24 | $278.8M | $184.5M | ||
| Q3 24 | $267.8M | $247.4M | ||
| Q2 24 | $217.4M | $151.4M | ||
| Q1 24 | $238.8M | $238.9M |
自由现金流EHCRBLX
| Q4 25 | $116.7M | $308.6M | ||
| Q3 25 | $83.7M | $443.6M | ||
| Q2 25 | $113.3M | $176.7M | ||
| Q1 25 | $125.5M | $426.5M | ||
| Q4 24 | $80.1M | $120.6M | ||
| Q3 24 | $120.3M | $218.0M | ||
| Q2 24 | $60.5M | $111.7M | ||
| Q1 24 | $99.4M | $192.3M |
自由现金流率EHCRBLX
| Q4 25 | 7.6% | 21.8% | ||
| Q3 25 | 5.7% | 32.6% | ||
| Q2 25 | 7.8% | 16.3% | ||
| Q1 25 | 8.6% | 41.2% | ||
| Q4 24 | 5.7% | 12.2% | ||
| Q3 24 | 8.9% | 23.7% | ||
| Q2 24 | 4.6% | 12.5% | ||
| Q1 24 | 7.6% | 24.0% |
资本支出强度EHCRBLX
| Q4 25 | 14.8% | 21.1% | ||
| Q3 25 | 12.7% | 7.5% | ||
| Q2 25 | 10.8% | 2.1% | ||
| Q1 25 | 11.2% | 1.7% | ||
| Q4 24 | 14.1% | 6.5% | ||
| Q3 24 | 10.9% | 3.2% | ||
| Q2 24 | 12.1% | 4.4% | ||
| Q1 24 | 10.6% | 5.8% |
现金转化率EHCRBLX
| Q4 25 | 2.37× | — | ||
| Q3 25 | 2.14× | — | ||
| Q2 25 | 1.90× | — | ||
| Q1 25 | 1.90× | — | ||
| Q4 24 | 2.31× | — | ||
| Q3 24 | 2.48× | — | ||
| Q2 24 | 1.91× | — | ||
| Q1 24 | 2.12× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EHC
| Medicare | $1.0B | 66% |
| Medicare Advantage | $243.1M | 16% |
| Managed Care | $160.7M | 10% |
| Medicaid | $47.0M | 3% |
| Other Income Source | $44.8M | 3% |
| Other Thirdparty Payors | $11.2M | 1% |
| Workers Compensation | $7.6M | 0% |
| Patients | $4.6M | 0% |
RBLX
暂无分部数据
